We are exiting our position in Bausch Health , selling 2,930 shares at roughly $7.13. In addition, are buying 95 shares of Abbott Laboratories at roughly $104.53 and 125 shares of GE Healthcare at roughly $81. Following the trades, Jim Cramer's Charitable Trust will own 895 shares of ABT, increasing its weighting to 2.95% from 2.65% and 1,275 shares of GEHC, increasing its weighting to 3.25% from. The Trust will no longer own a position in BHC.
Many analysts think the market capitalization that has been lost from this overhang far exceeds what Abbott could ultimately pay to settle the cases, creating an opportunity to buy a Dividend Aristocrat on weakness. This will be our fourth Abbott buy since mid-March. GE Healthcare's first-quarter report on April 30 was not clean . We acknowledge that.